Published 13 May 2020
Introduction
In recent weeks, at least seven class action lawsuits have
been filed in federal district courts throughout the United
States against the government of the People's Republic of China
(the "P.R.C." or "China"), all relating to China's alleged
liability for damages and injuries sustained in the ongoing
COVID-19 pandemic. Although plaintiffs in these lawsuits make
broadly different claims, they all face the same highly
formidable legal roadblock: a need to find exceptions that can
pierce the presumptive immunity afforded to China and other
sovereign nations under the Foreign Sovereign Immunities Act
("FSIA"), 28 U.S.C. § 1602, et seq., which would
otherwise preclude their claims at the outset for lack of
jurisdiction.
To read this article you need to be a subscriber
Subscribe
Fill in the registration form and answer a few simple questions to receive a quote.
Subscribe now
Suggested Citation
M. Diaz, Jr.; M. Colomar-Garcia; B.C. Hadaway; G.E. Davidson; X.J. Zhao; J. Coronado; Z. Pan (2020, forthcoming) "The Façade of COVID-19 Class Action Litigation Against China Under the Foreign Sovereign Immunities Act"
(TDM, ISSN 1875-4120) May 2020, www.transnational-dispute-management.com
Other recently published material:
Algunas consideraciones entorno a la protección efectiva de las inversiones del sector energético en México
26 July 2022
New Frontiers in Asia-Pacific International Arbitration and Dispute Resolution - Book Review
1 July 2022
Forming Transnational Dispute Settlement Norms: Soft Law and the Role of UNCITRAL's Regional Centre for Asia and the Pacific - Book Review
1 July 2022
From Protection to Facilitation Agreements: Contributions of The Pan-African Investment Code, the Brazilian Model, and the New Regional and Multilateral Foreign Investments Agreements
27 June 2022
Oded Besserglik v Mozambique: Lessons for Improving Investor-State Dispute Settlement in Africa
27 June 2022
Complete listing of Advance publication.